Academic Journal

Testosterone status and bone mineral density in Finnish male endurance athletes: Baseline associations and 1-year follow-up.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Τίτλος: Testosterone status and bone mineral density in Finnish male endurance athletes: Baseline associations and 1-year follow-up.
Συγγραφείς: Wagner A; Department of Sport Performance and Exercise Testing, Faculty of Sport Studies, Masaryk University, Brno, Czech Republic.; University of Jyväskylä, Faculty of Sport and Health Sciences, Jyväskylä, Finland., Mjøsund K; National Olympic Training Centre, Helsinki, Finland.; Paavo Nurmi Centre and Unit for Health and Physical Activity, University of Turku, Turku, Varsinais-Suomi, Finland., Komonen R; Finnish Institute of High-Performance Sport KIHU, Jyväskylä, Finland., Hackney AC; Department of Exercise & Sport Science-Department of Nutrition, University of North Carolina, Chapel Hill, North Carolina, USA., Ihalainen JK; University of Jyväskylä, Faculty of Sport and Health Sciences, Jyväskylä, Finland.; Finnish Institute of High-Performance Sport KIHU, Jyväskylä, Finland.
Πηγή: Physiological reports [Physiol Rep] 2026 Jun; Vol. 14 (11), pp. e70972.
Τύπος έκδοσης: Journal Article
Γλώσσα: English
Στοιχεία περιοδικού: Publisher: published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society Country of Publication: United States NLM ID: 101607800 Publication Model: Print Cited Medium: Internet ISSN: 2051-817X (Electronic) Linking ISSN: 2051817X NLM ISO Abbreviation: Physiol Rep Subsets: MEDLINE
Imprint Name(s): Original Publication: [Malden MA] : published by Wiley Periodicals, Inc. on behalf of the American Physiological Society and The Physiological Society, 2013-
Ιατρικοί όροι (MeSH): Testosterone*/blood , Bone Density*/physiology , Physical Endurance*/physiology , Athletes*, Insulin-Like Growth Factor I/metabolism ; Hydrocortisone/blood ; Humans ; Male ; Finland ; Adult ; Young Adult ; Follow-Up Studies
Περίληψη: This study examined whether low-normal serum total testosterone (T) is associated with bone mineral density (BMD) or bone stress injuries (BSI) in male endurance athletes. Baseline data from 46 national- to international-level Finnish athletes (age 24.8 ± 3.6 years; biathlon, cross-country skiing, orienteering, triathlon, Nordic combined, endurance running) were analyzed; 31 completed 1-year follow-up. Participants were categorized into low T (lowest quartile: 11.8 ± 1.8 nmol/L) and normal T groups (17.9 ± 3.1 nmol/L; p < 0.001). At baseline, BMD and Z-scores did not differ at any site (all p > 0.5), and BSI history prevalence was similar in low T (41.7%) and normal T groups (29.4%). The low T group had lower IGF-1 (p = 0.031) but comparable cortisol and insulin. During follow-up, repeated-measures analysis showed a significant group-by-time interaction for T (p = 0.001), whereas 1-year changes in BMD and Z-scores did not differ between groups. Regression models showed that increased IGF-1 independently predicted improved total body BMD (p = 0.01). In conclusion, low-normal T in elite male endurance athletes was not associated with compromised bone health over 1 year and appeared largely reversible in the follow-up subset.
(© 2026 The Author(s). Physiological Reports published by Wiley Periodicals LLC on behalf of The Physiological Society and the American Physiological Society.)
References: PLoS Med. 2005 Aug;2(8):e124. (PMID: 16060722)
J Clin Endocrinol Metab. 2014 Jan;99(1):30-8. (PMID: 24384013)
J Appl Physiol (1985). 1992 Sep;73(3):1165-70. (PMID: 1400032)
Br J Sports Med. 2023 Sep;57(17):1073-1097. (PMID: 37752011)
Front Endocrinol (Lausanne). 2020 Jan 31;11:11. (PMID: 32082255)
J Clin Endocrinol Metab. 2018 May 1;103(5):1715-1744. (PMID: 29562364)
PLoS One. 2019 Mar 8;14(3):e0213681. (PMID: 30849119)
Front Endocrinol (Lausanne). 2024 Jan 03;14:1287972. (PMID: 38239981)
Front Physiol. 2021 Jan 15;11:621226. (PMID: 33519525)
Calcif Tissue Int. 2022 May;110(5):605-614. (PMID: 35171303)
Eur J Transl Myol. 2023 Apr 11;33(2):. (PMID: 37052052)
Int J Sport Nutr Exerc Metab. 2015 Apr;25(2):198-215. (PMID: 25029265)
Clin Endocrinol (Oxf). 2012 Mar;76(3):339-45. (PMID: 21942923)
Int J Sport Nutr Exerc Metab. 2018 Jul 1;28(4):403-411. (PMID: 29252050)
Ann Clin Lab Sci. 1995 Sep-Oct;25(5):381-8. (PMID: 7486812)
Int J Sports Physiol Perform. 2018 Oct 1;13(9):1158-1163. (PMID: 29584528)
Sports Med. 2016 Feb;46(2):171-82. (PMID: 26497148)
Endocr Rev. 2018 Oct 1;39(5):803-829. (PMID: 30010735)
Eur J Nutr. 2024 Oct;63(7):2655-2665. (PMID: 38953963)
Clin Endocrinol (Oxf). 1998 Apr;48(4):493-501. (PMID: 9640417)
Nat Rev Urol. 2015 Nov;12(11):641-50. (PMID: 26458755)
Eur J Appl Physiol. 2017 Jul;117(7):1349-1357. (PMID: 28470410)
Am J Sports Med. 2015 Jun;43(6):1494-504. (PMID: 25748470)
J Clin Med. 2021 Feb 02;10(3):. (PMID: 33540526)
Int J Biol Macromol. 2023 May 31;238:124125. (PMID: 36948334)
J Clin Endocrinol Metab. 2005 May;90(5):2941-7. (PMID: 15713723)
Front Nutr. 2021 Nov 26;8:737777. (PMID: 34901104)
Med Sci Sports Exerc. 2019 Feb;51(2):234-236. (PMID: 30212398)
Medicine (Baltimore). 2022 Sep 30;101(39):e30735. (PMID: 36181112)
J Sports Sci. 2016 Oct;34(20):1921-9. (PMID: 26852783)
Front Endocrinol (Lausanne). 2013 Feb 04;4:6. (PMID: 23382729)
Sports Med. 2021 Mar;51(3):391-403. (PMID: 33346900)
Am J Sports Med. 2014 Apr;42(4):949-58. (PMID: 24567250)
Int J Sports Physiol Perform. 2022 Dec 29;17(2):317-331. (PMID: 34965513)
J Clin Endocrinol Metab. 2023 Sep 18;108(10):e1063-e1073. (PMID: 37079740)
Med Sci Sports Exerc. 1988 Feb;20(1):60-5. (PMID: 3343919)
Int J Sport Nutr Exerc Metab. 2018 Jul 1;28(4):335-349. (PMID: 30008240)
Horm Res. 2003;59(6):285-92. (PMID: 12784093)
Curr Trends Endocinol. 2005;1:101-106. (PMID: 31723314)
Appl Physiol Nutr Metab. 2022 Mar;47(3):328-336. (PMID: 34807739)
Br J Sports Med. 2019 Feb;53(4):237-242. (PMID: 30580252)
Grant Information: OKM/10/626/2021 Ministry of Education and Culture, Finland | Taiteen edistämiskeskus (Taike); OKM/78/626/2022 Ministry of Education and Culture, Finland | Taiteen edistämiskeskus (Taike)
Contributed Indexing: Keywords: IGF‐1; bone mineral density; endurance athletes; testosterone
Substance Nomenclature: 3XMK78S47O (Testosterone)
67763-96-6 (Insulin-Like Growth Factor I)
WI4X0X7BPJ (Hydrocortisone)
Entry Date(s): Date Created: 20260610 Date Completed: 20260614 Latest Revision: 20260813
Update Code: 20260813
PubMed Central ID: PMC13250475
DOI: 10.14814/phy2.70972
PMID: 42266098
Βάση Δεδομένων: MEDLINE
Περιγραφή
ISSN:2051-817X
DOI:10.14814/phy2.70972